OTCMKTS:ALNRF Mediclinic International (ALNRF) Stock Price, News & Analysis → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free ALNRF Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$4.65▼$4.6550-Day Range N/A52-Week Range$12.29▼$12.29VolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Mediclinic International alerts: Email Address Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> About Mediclinic International Stock (OTCMKTS:ALNRF)Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers acute care, specialist-orientated, and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 74 hospitals, 18 day case clinics, 18 outpatient clinics, 5 subacute hospitals, 2 mental health facilities, and 454 theatres with approximately 11,?449 inpatient beds in Switzerland, South Africa, Namibia, and the United Arab Emirates. The company also provides treasury, hospital equipment and procurement, emergency medical, management, food and catering, healthcare management, and debt collection and related services; manages healthcare staff; and owns and manages properties. In addition, it engages in intellectual property holding and medical store/procurement businesses. The company was founded in 1983 and is based in Stellenbosch, South Africa.Read More Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> ALNRF Stock News HeadlinesMarch 16, 2023 | finanznachrichten.deMagnetar Capital Partners LP - Form 8.3 - Mediclinic International plcSeptember 18, 2022 | msn.comMoHAP inks partnership deal with Mediclinic Middle EastApril 19, 2024 | Stansberry Research (Ad)The "Smart Money" Is Ready for May 1st Are You?Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company. August 6, 2022 | reuters.comConsortium to buy South Africa hospitals firm Mediclinic for $4.49 billionAugust 6, 2022 | nasdaq.comConsortium to buy S.Africa hospitals firm Mediclinic for $4.49 blnAugust 5, 2022 | msn.comMediclinic accepts Remgro consortium’s £3.7bn offerAugust 4, 2022 | msn.comMediclinic’s board accepts improved offer by Remgro firm and MSC Shipping consortiumAugust 4, 2022 | reuters.comUK's Mediclinic to be bought by consortium in $4.49 bln dealApril 19, 2024 | Stansberry Research (Ad)The "Smart Money" Is Ready for May 1st Are You?Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company. June 1, 2022 | msn.comWhat Is the Medi-Weightloss Program?February 10, 2022 | finance.yahoo.comWhat Type Of Shareholders Own The Most Number of Mediclinic International plc (LON:MDC) Shares?January 23, 2022 | msn.comJPMORGAN: 'Big upside opportunities' can be found in small-cap stocks where 5 major tailwinds should drive outperformance in 2022. Here are 31 'smid-cap' picks to buy ...November 2, 2021 | finance.yahoo.comInvestors in Mediclinic International (LON:MDC) have unfortunately lost 60% over the last five yearsSeptember 21, 2021 | marketwatch.comMediclinic International Refinances Southern Africa Division's Debt Through New FacilityAugust 27, 2021 | lse.co.ukHSBC upgrades Mediclinic to 'buy'August 26, 2021 | lse.co.ukMediclinic International Share ChatJuly 28, 2021 | marketwatch.comMediclinic International Says YTD Operating Performance in Line With GuidanceSee More Headlines Receive ALNRF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Mediclinic International and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Care Facilities Sub-IndustryN/A Current SymbolOTCMKTS:ALNRF CUSIPN/A CIKN/A Webwww.mediclinic.com Phone27 21 809 6500FaxN/AEmployees33,719Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesDr. Carel Aron van der Merwe (Age 58)Group CEO & Exec. Director Comp: $827.76kMr. Petrus Jurgens Myburgh (Age 46)Group CFO & Exec. Director Comp: $608.77kDr. Dirk C. Le Roux (Age 61)Group Chief Information Officer Mr. James ArnoldHead of Investor RelationsMr. Magnus U. Oetiker (Age 49)Group Chief Strategy and HR Officer Mr. Gert C. Hattingh (Age 56)Group Chief Governance Officer Mr. Biren ValodiaChief Marketing Officer of Medi-Clinic Southern AfricaMs. Clara FindlayChief Legal Officer of Medicalinic Southern AfricaMr. Wimpie AucampChief Operating Officer of Medi-Clinic for Southern AfricaGreg Van WykChief HR Officer of Medicalinic Southern AfricaMore ExecutivesKey CompetitorsAmerican Oncology NetworkNASDAQ:AONCWAmerican Oncology NetworkNASDAQ:AONCBangkok Dusit Medical Services PublicOTCMKTS:BDULFBumrungrad Hospital PublicOTCMKTS:BUHPFCareRxOTCMKTS:CHHHFView All Competitors This page (OTCMKTS:ALNRF) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIYour Money is Not SafeAmerican AlternativeHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceSHOCKING Crypto Leak…Crypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mediclinic International plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.